Premium
Associations between peak oxygen uptake, lung function, and bronchiectasis in children with cystic fibrosis in the era of CFTR modulators
Author(s) -
Du Berry Cassidy,
Westrupp Nicole,
Shanthikumar Shivanthan,
Welsh Liam
Publication year - 2021
Publication title -
pediatric pulmonology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.866
H-Index - 106
eISSN - 1099-0496
pISSN - 8755-6863
DOI - 10.1002/ppul.25275
Subject(s) - medicine , spirometry , cystic fibrosis , bronchiectasis , pulmonary function testing , vo2 max , vital capacity , cardiology , body mass index , cystic fibrosis transmembrane conductance regulator , lung , lung volumes , respiratory disease , gastroenterology , physical therapy , lung function , asthma , diffusing capacity , heart rate , blood pressure
Background With the emergence of cystic fibrosis transmembrane conductance regulator (CFTR) modulators, forced expiratory volume in 1 s (FEV 1 ) may become a less sensitive measure of pulmonary disease progression in children with cystic fibrosis (CF). Increasing evidence shows that peak oxygen uptake (VO 2peak ) is a strong predictor of prognosis in CF. The primary aim of this study was to describe the associations between peak oxygen uptake, lung function, and bronchiectasis in children with CF in the era of CFTR modulators. Methods Spirometry and a maximal cardiopulmonary exercise test (CPET) were performed on the same day and compared to markers of disease severity. Markers of disease severity included a number of pulmonary exacerbations resulting in hospital admission within the preceding 12 months, body mass index, Pseudomonas aeruginosa ( PsA ) infection, and bronchiectasis. Results Fifty‐two subjects (24 female) with CF participated in the study with a mean ( SD ) age of 13.8 (2.4) years, range 8–18 years. Forty‐nine participants met satisfactory criteria for a maximal CPET. A significant correlation was found between relative VO 2peak %predicted and FEV 1 %predicted ( r = .546, p < .001). A total of 4/49 children demonstrated an impaired aerobic capacity despite normal spirometry. Participants who had experienced one or more pulmonary exacerbations in the previous 12 months had a significantly lower relative VO 2peak %predicted ( p = .02). Conclusions In children with CF who have mild pulmonary disease, there is significant correlation between FEV 1 and VO 2peak . In all, 8.2% of participants had an abnormal CPET result despite normal spirometry, and preceding pulmonary exacerbations were associated with poorer CPET outcomes. CPET may offer important prognostic information for clinical decision making in this new era of CFTR modulators.